- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
An Overview of Angiogenesis in Bladder Cancer ; volume:25 ; number:7 ; day:13 ; month:4 ; year:2023 ; pages:709-728 ; date:7.2023
Current oncology reports ; 25, Heft 7 (13.4.2023), 709-728, 7.2023
- Urheber
-
Elayat, Ghada
Punev, Ivan
Selim, Abdel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-023-01421-5
- URN
-
urn:nbn:de:101:1-2023091908500065652478
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elayat, Ghada
- Punev, Ivan
- Selim, Abdel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of tyrosine kinases in bladder cancer progression: an overview
Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
Angiogenesis in Cancer
Bladder cancer
Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
Treatment of bladder cancer
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Platelets and cancer angiogenesis nexus
Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer
Intravesical Treatments of Bladder Cancer: Review
Role of tyrosine kinases in bladder cancer progression: an overview
Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
Angiogenesis in Cancer
Bladder cancer
Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
Treatment of bladder cancer
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Platelets and cancer angiogenesis nexus
Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer
Intravesical Treatments of Bladder Cancer: Review
Role of tyrosine kinases in bladder cancer progression: an overview
Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
Angiogenesis in Cancer
Bladder cancer
Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
Treatment of bladder cancer
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Platelets and cancer angiogenesis nexus
Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer